Filing Details
- Accession Number:
- 0001206386-15-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-17 18:32:26
- Reporting Period:
- 2015-09-16
- Filing Date:
- 2015-09-17
- Accepted Time:
- 2015-09-17 18:32:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206386 | M Richard Marsh | 320 Wakara Way Salt Lake City UT 84108 | E.v.p., General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-16 | 35,000 | $22.93 | 109,227 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-16 | 35,000 | $41.25 | 74,227 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-17 | 6,684 | $41.39 | 67,543 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-09-16 | 35,000 | $0.00 | 35,000 | $22.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,000 | 2018-09-10 | No | 4 | M | Direct |
Footnotes
- Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
Billionaire Hedge Funds
